Home
Science
About
News
We are a pre-clinical stage biotechnology company with a mission to treat solid tumors and arthritic disorders that depend on extracellular matrix (ECM) remodeling.
TEAM
Frederic Bard
CEO & Scientific Founder
Florian Schuster
Investor & Advisor
Guy Heathers
CBO & Business Co-Founder
Kristina Rutkute
Director, Business Development
Cheng-I Wang
Head of Antibody Development
Christopher Tan
Board Member
Home
Science
About
News